Traditional HKGs such as Gapdh and Actb are frequently utilized as internal reference controls in both genomic and proteomic studies, however, in many cases, are inappropriately selected due to their expression variability between experimental conditions or pathologies such as inflammatory diseases and cancers [26,27]. This evidence concerns the gene GAPDH and cancer.